Experiment 653430

Details

PropertyValue
Pharmacology
Administration routeROUTE NOT GIVEN
OrganismValeriana officinalis (VALERIANACEAE)
CitationHOUGHTON,PJ:. (1999). THE SCIENTIFIC BASIS FOR THE REPUTED ACTIVITY OF VALERIAN.. 51(5)
Amount utilized
Compound isolated
DiseaseIT HAS RECENTLY BEEN REPORTED THAT THE LIGNAN 1-HYDROXYPINORESINOL INHIBITS 5-HYDROXYTRYPTAMINE BINDING TO ITS RECEPTOR IN ISOLATED BRAIN TISSUE BUT HAS LITTLE EFFECT ON THE BENZODIAZEPINE RECEPTOR. LITTLE INFORMATION IS AVAILABLE ABOUT THE AMOUNTS OF THIS COMPOUND IN VALERIAN OR ITS PREPARATIONS BUT THE POSSIBILITY OF YET ANOTHER FACTOR LEADING TO CNS SEDATION, I.E. INHIBITION OR AGONISM OF 5-HYDROXYTRYPTAMINE DEPENDING ON THE PART OF THE BRAIN, IS AN INTERESTING ASPECT OF THE CHEMICAL BASIS FOR THE OBSERVED EFFECTS OF VALERIAN.
Number10
Qualitative resultEQUIVOCAL
AnimalSPECIES NOT STATED
Dose expressionDOSE
ExtractTYPE EXT NOT STATED